English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksTorrent Pharmaceuticals share price falls 2.04% in today's trading

    Torrent Pharmaceuticals share price falls 2.04% in today's trading

    With the stock's last traded price at Rs 3,541.00, Torrent Pharmaceuticals reflects a noteworthy movement in today's session.

    Alpha Desk
    September 25, 2025 / 15:08 IST
    Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Shares of Torrent Pharmaceuticals declined by 2.04% to Rs 3,541.00 in Thursday's session. The stock is a constituent of the NIFTY NEXT 50 index.

      Financial Performance:

      Consolidated Quarterly Results:

      Torrent Pharmaceuticals has demonstrated strong financial performance in its consolidated quarterly results.

      HeadingJun 2024Sep 2024Dec 2024Mar 2025Jun 2025
      RevenueRs 2,859.00 CroreRs 2,889.00 CroreRs 2,809.00 CroreRs 2,959.00 CroreRs 3,178.00 Crore
      Net ProfitRs 457.00 CroreRs 453.00 CroreRs 503.00 CroreRs 498.00 CroreRs 548.00 Crore
      EPS13.5113.3714.8814.7116.19

      Revenue for the quarter-ending June 2025 stood at Rs 3,178.00 Crore, showing an increase compared to previous quarters. Net profit for the same period was Rs 548.00 Crore. The EPS for June 2025 was reported as 16.19.

      Consolidated Yearly Results:

      The company's consolidated yearly results also reflect a positive trend.

      Heading20212022202320242025
      RevenueRs 8,004.57 CroreRs 8,508.04 CroreRs 9,620.15 CroreRs 10,727.84 CroreRs 11,516.09 Crore
      Net ProfitRs 1,251.88 CroreRs 777.18 CroreRs 1,245.23 CroreRs 1,656.38 CroreRs 1,911.25 Crore
      EPS73.9845.9336.7948.9456.47
      BVPS344.90351.75183.13202.57224.27
      ROE21.4413.0520.0924.1525.17
      Debt to Equity0.830.670.850.570.40

      The revenue for the year-ending March 2025 was Rs 11,516.09 Crore, an increase from Rs 10,727.84 Crore in the previous year. Net profit also increased to Rs 1,911.25 Crore. The EPS rose to 56.47, and the debt-to-equity ratio decreased to 0.40.

      Income Statement:

      The income statement provides a detailed breakdown of the company's financial performance.

      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      SalesRs 11,516 CroreRs 10,727 CroreRs 9,620 CroreRs 8,508 CroreRs 8,004 Crore
      Other IncomeRs 23 CroreRs 57 CroreRs 45 CroreRs 196 CroreRs 56 Crore
      Total IncomeRs 11,539 CroreRs 10,785 CroreRs 9,665 CroreRs 8,704 CroreRs 8,061 Crore
      Total ExpenditureRs 8,614 CroreRs 8,080 CroreRs 7,484 CroreRs 7,223 CroreRs 6,182 Crore
      EBITRs 2,925 CroreRs 2,705 CroreRs 2,180 CroreRs 1,480 CroreRs 1,879 Crore
      InterestRs 252 CroreRs 353 CroreRs 333 CroreRs 255 CroreRs 352 Crore
      TaxRs 761 CroreRs 695 CroreRs 601 CroreRs 448 CroreRs 274 Crore
      Net ProfitRs 1,911 CroreRs 1,656 CroreRs 1,245 CroreRs 777 CroreRs 1,251 Crore

      The quarterly income statement also shows positive figures.
      Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      SalesRs 3,178 CroreRs 2,959 CroreRs 2,809 CroreRs 2,889 CroreRs 2,859 Crore
      Other IncomeRs -37 CroreRs -18 CroreRs 33 CroreRs -16 CroreRs 24 Crore
      Total IncomeRs 3,141 CroreRs 2,941 CroreRs 2,842 CroreRs 2,873 CroreRs 2,883 Crore
      Total ExpenditureRs 2,347 CroreRs 2,220 CroreRs 2,094 CroreRs 2,148 CroreRs 2,152 Crore
      EBITRs 794 CroreRs 721 CroreRs 748 CroreRs 725 CroreRs 731 Crore
      InterestRs 56 CroreRs 56 CroreRs 57 CroreRs 64 CroreRs 75 Crore
      TaxRs 190 CroreRs 167 CroreRs 188 CroreRs 208 CroreRs 199 Crore
      Net ProfitRs 548 CroreRs 498 CroreRs 503 CroreRs 453 CroreRs 457 Crore
      Cash Flow:

      The company's cash flow from operating activities remains robust.

      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Operating ActivitiesRs 2,585 CroreRs 3,266 CroreRs 2,368 CroreRs 1,802 CroreRs 2,010 Crore
      Investing ActivitiesRs -540 CroreRs -167 CroreRs -2,415 CroreRs -196 CroreRs -449 Crore
      Financing ActivitiesRs -2,297 CroreRs -2,779 CroreRs 77 CroreRs -1,781 CroreRs -1,656 Crore
      OthersRs -8 CroreRs 8 CroreRs 79 CroreRs 0 CroreRs 5 Crore
      Net Cash FlowRs -261 CroreRs 326 CroreRs 110 CroreRs -174 CroreRs -89 Crore
      Balance Sheet:

      The balance sheet provides insight into the company's assets and liabilities.

      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Share CapitalRs 169 CroreRs 169 CroreRs 169 CroreRs 84 CroreRs 84 Crore
      Reserves & SurplusRs 7,421 CroreRs 6,686 CroreRs 6,028 CroreRs 5,868 CroreRs 5,752 Crore
      Current LiabilitiesRs 4,717 CroreRs 5,425 CroreRs 5,447 CroreRs 4,415 CroreRs 4,891 Crore
      Other LiabilitiesRs 2,681 CroreRs 2,779 CroreRs 3,366 CroreRs 2,731 CroreRs 3,345 Crore
      Total LiabilitiesRs 14,989 CroreRs 15,060 CroreRs 15,011 CroreRs 13,099 CroreRs 14,074 Crore
      Fixed AssetsRs 8,086 CroreRs 8,160 CroreRs 8,549 CroreRs 6,792 CroreRs 7,612 Crore
      Current AssetsRs 5,622 CroreRs 5,611 CroreRs 5,329 CroreRs 5,294 CroreRs 5,523 Crore
      Other AssetsRs 1,281 CroreRs 1,288 CroreRs 1,133 CroreRs 1,012 CroreRs 938 Crore
      Total AssetsRs 14,989 CroreRs 15,060 CroreRs 15,011 CroreRs 13,099 CroreRs 14,074 Crore
      Contingent LiabilitiesRs 465 CroreRs 575 CroreRs 619 CroreRs 505 CroreRs 324 Crore
      Ratios:

      Key financial ratios provide insights into the company's performance and efficiency.

      Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
      Basic EPS (Rs.)56.4748.9436.7945.9373.98
      Diluted Eps (Rs.)56.4748.9436.7945.9373.98
      Book Value /Share (Rs.)224.27202.57183.13351.75344.90
      Dividend/Share (Rs.)32.0028.0022.0048.0035.00
      Face Value55555
      Gross Profit Margin (%)32.5131.9330.0130.8831.69
      Operating Margin (%)25.6124.3922.6623.1023.47
      Net Profit Margin (%)16.5915.4412.949.1315.63
      Return on Networth / Equity (%)25.1724.1520.0913.0521.44
      ROCE (%)28.7127.1622.7922.6320.46
      Return On Assets (%)12.7510.998.295.938.89
      Current Ratio (X)1.191.030.981.201.13
      Quick Ratio (X)0.650.610.570.640.58
      Debt to Equity (x)0.400.570.850.670.83
      Interest Coverage Ratios (X)14.849.698.6610.307.19
      Asset Turnover Ratio (%)0.770.710.680.530.50
      Inventory Turnover Ratio (X)4.700.740.630.680.70
      3 Yr CAGR Sales (%)16.3415.7710.085.3015.67
      3 Yr CAGR Net Profit (%)56.8215.0310.2433.4635.87
      P/E (x)57.1653.1441.7830.3917.20
      P/B (x)14.4212.848.407.957.37
      EV/EBITDA (x)29.8926.6019.6619.3818.62
      P/S (x)9.518.215.415.565.37
      Corporate Actions:

      Torrent Pharmaceuticals has announced several corporate actions, including the issue and redemption of commercial papers. The company announced a final dividend of Rs 6.00 per share (120%) on May 20, 2025, with an effective date of June 20, 2025. Prior to that, an interim dividend of Rs 26.00 per share (520%) was announced on January 14, 2025, effective January 31, 2025.

      The company also has a history of bonus issues, with the most recent one declared on May 25, 2022, in the ratio of 1:1, with an ex-bonus date of July 8, 2022.

      Additionally, Torrent Pharmaceuticals underwent a stock split on February 20, 2006, where the face value was split from Rs 10 to Rs 5.

      With the stock's last traded price at Rs 3,541.00, Torrent Pharmaceuticals reflects a noteworthy movement in today's session.

      Alpha Desk
      first published: Sep 25, 2025 03:08 pm

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347